FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169353837> ?p ?o ?g. }

• W2169353837 endingPage "18503" @default.
• W2169353837 startingPage "18498" @default.
• W2169353837 abstract "Post-translational protein modifications can be recognized by B and T lymphocytes and can potentially make “self”-proteins appear foreign to the immune system. Such modifications may directly affect major histocompatibility complex-restricted T cell recognition of processed peptides or may perturb the processing events that generate such peptides. Using the tetanus toxin C fragment protein as a test case, we show that spontaneous deamidation of asparagine residues interferes with processing by the enzyme asparagine endopeptidase (AEP) and contributes to diminished antigen presentation. Deamidation inhibits AEP action either directly, when asparagine residues targeted by AEP are modified, or indirectly, when adjacent Asn residues are deamidated. Thus, deamidation of long-lived self-proteins may qualitatively or quantitatively affect the spectrum of self-peptides displayed to T cells and may thereby contribute to the onset or exacerbation of autoimmune disease. Post-translational protein modifications can be recognized by B and T lymphocytes and can potentially make “self”-proteins appear foreign to the immune system. Such modifications may directly affect major histocompatibility complex-restricted T cell recognition of processed peptides or may perturb the processing events that generate such peptides. Using the tetanus toxin C fragment protein as a test case, we show that spontaneous deamidation of asparagine residues interferes with processing by the enzyme asparagine endopeptidase (AEP) and contributes to diminished antigen presentation. Deamidation inhibits AEP action either directly, when asparagine residues targeted by AEP are modified, or indirectly, when adjacent Asn residues are deamidated. Thus, deamidation of long-lived self-proteins may qualitatively or quantitatively affect the spectrum of self-peptides displayed to T cells and may thereby contribute to the onset or exacerbation of autoimmune disease. Asparagine deamidation is the most common spontaneous post-translational protein modification and is increasingly recognized as having an important impact on protein function. For example, a recent study demonstrated that the DNA-damaging antineoplastic drug cisplatin induced the deamidation of two asparagine residues in a flexible loop of the antiapoptotic protein Bcl-xL, preventing its interaction with other proapoptotic Bcl family members and thereby inducing apoptosis (1Deverman B.E. Cook B.L. Manson S.R. Niederhoff R.A. Langer E.M. Rosova I. Kulans L.A. Fu X. Weinberg J.S. Heinecke J.W. Roth K.A. Weintraub S.J. Cell. 2002; 111: 51-62Abstract Full Text Full Text PDF PubMed Scopus (196) Google Scholar). Other studies document the deleterious effects of asparagine deamidation on the CD4 binding activity of human immunodeficiency virus gp120 (2Teshima G. Porter J. Yim K. Ling V. Guzzetta A. Biochemistry. 1991; 30: 3916-3922Crossref PubMed Scopus (47) Google Scholar), the co-mitogenic and receptor binding activity of murine IL1-β 1The abbreviations used are: IL, interleukin; TTCF, tetanus toxin C fragment; AEP, asparagine endopeptidase; MBP, myelin basic protein; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; HPLC, high pressure liquid chromatography; MALDI-TOF, matrix-assisted laser desorption/ionization-time of flight; MALDI-TOF/TOF, MALDI-time of flight/time of flight; MS, mass spectrometry; Bi, biotinylated. 1The abbreviations used are: IL, interleukin; TTCF, tetanus toxin C fragment; AEP, asparagine endopeptidase; MBP, myelin basic protein; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; HPLC, high pressure liquid chromatography; MALDI-TOF, matrix-assisted laser desorption/ionization-time of flight; MALDI-TOF/TOF, MALDI-time of flight/time of flight; MS, mass spectrometry; Bi, biotinylated. (3Daumy G.O. Wilder C.L. Merenda J.M. McColl A.S. Geoghegan K.F. Otterness I.G. FEBS Lett. 1991; 278: 98-102Crossref PubMed Scopus (19) Google Scholar), and the angiogenic activity of angiogenin (4Hallahan T.W. Shapiro R. Strydom D.J. Vallee B.L. Biochemistry. 1992; 31: 8022-8029Crossref PubMed Scopus (67) Google Scholar). Immune recognition of proteins and peptides can also be affected by deamidation/isomerization of asparagine and glutamine residues. For example, T cells have been described that specifically recognize peptides containing asparagine residues that have either cyclized (5Chen W. Ede N.J. Jackson D.C. McCluskey J. Purcell A.W. J. Immunol. 1996; 157: 1000-1005PubMed Google Scholar) or become deamidated to aspartic acid (6Cirrito T.P. Pu Z. Deck M.B. Unanue E.R. J. Exp. Med. 2001; 194: 1165-1169Crossref PubMed Scopus (22) Google Scholar, 7McAdam S.N. Fleckenstein B. Rasmussen I.B. Schmid D.G. Sandlie I. Bogen B. Viner N.J. Sollid L.M. J. Exp. Med. 2001; 193: 1239-1246Crossref PubMed Scopus (33) Google Scholar). As has been pointed out (8Doyle H.A. Mamula M.J. Trends Immunol. 2001; 22: 443-449Abstract Full Text Full Text PDF PubMed Scopus (235) Google Scholar), the appearance of such modifications in “self”-proteins may disturb the delicate balance that the immune system establishes between tolerance to self-proteins on the one hand but an ability to respond to foreign entities on the other. For example, mice showed no response to unmodified forms of a self-cytochrome c peptide (90-104) or to a small nuclear ribonucleoprotein D peptide (65-79) but developed strong T and B cell responses to forms of these peptides in which a single Asp residue had been modified to iso-Asp (9Mamula M.J. Gee R.J. Elliott J.I. Sette A. Southwood S. Jones P.J. Blier P.R. J. Biol. Chem. 1999; 274: 22321-22327Abstract Full Text Full Text PDF PubMed Scopus (175) Google Scholar). Importantly, the B cell response to the iso-Asp containing peptide cross-reacted with the native protein, suggesting a plausible chain of events initiated by post-translational protein modification that may lead to autoreactivity. In the case of α-gliadin, a single glutamine residue, likely deamidated as a result of tissue transglutaminase action, is found in two overlapping T cell epitopes recognized by T cells from human leukocyte antigen-DQ2-positive celiac disease patients (10Molberg O. McAdam S.N. Korner R. Quarsten H. Kristiansen C. Madsen L. Fugger L. Scott H. Noren O. Roepstorff P. Lundin K.E. Sjostrom H. Sollid L.M. Nat. Med. 1998; 4: 713-717Crossref PubMed Scopus (964) Google Scholar, 11Arentz-Hansen H. Korner R. Molberg O. Quarsten H. Vader W. Kooy Y.M. Lundin K.E. Koning F. Roepstorff P. Sollid L.M. McAdam S.N. J. Exp. Med. 2000; 191: 603-612Crossref PubMed Scopus (548) Google Scholar). Proteolytic processing reactions are required before T cell epitopes are captured and displayed on major histocompatibility complex molecules. In the class II major histocompatibility complex pathway, a number of endosomal/lysosomal processing enzymes participate in these reactions (12Watts C. Nat. Immunol. 2004; 5: 685-692Crossref PubMed Scopus (193) Google Scholar), including a cysteine protease known as asparagine endopeptidase (AEP) or legumain that is highly specific for cleavage at Asn residues (13Chen J.M. Dando P.M. Rawlings N.D. Brown M.A. Young N.E. Stevens R.A. Hewitt E. Watts C. Barrett A.J. J. Biol. Chem. 1997; 272: 8090-8098Abstract Full Text Full Text PDF PubMed Scopus (284) Google Scholar, 14Manoury B. Hewitt E.W. Morrice N. Dando P.M. Barrett A.J. Watts C. Nature. 1998; 396: 695-699Crossref PubMed Scopus (300) Google Scholar). The identification of this enzyme raised the possibility that asparagine deamidation may additionally affect T cell recognition of proteins indirectly, by influencing the processing reactions that generate T cell epitopes. Using the tetanus toxin C fragment (TTCF) antigen as a test case, we explore this possibility here and demonstrate that spontaneous Asn deamidation readily occurs and that this can influence antigen processing and presentation. TTCF and TTCF Mutants—The TTCF, incorporating a hexa-histidine tag, was produced in BL21 Escherichia coli and purified using nickel-agarose as described (15Hewitt E.W. Treumann A. Morrice N. Tatnell P.J. Kay J. Watts C. J. Immunol. 1997; 159: 4693-4699PubMed Google Scholar). Single point mutations were introduced using the QuikChange mutagenesis kit (Stratagene) according to manufacturer's instructions. Asn-1183 was mutated to Asp using the following mutagenic PCR primers: forward, 5′-CAA ACG CTA CAC TCC GGA CAA CGA AAT CGA TTC-3′; reverse, 5′-GAA TCG ATT TCG TTG TCC GGA GTG TAG CGT TTG-3′. Peptides—TTCF peptides comprising residues 1178-1191 of the tetanus toxin sequence (KRYTPNNEIDSFVK, KRYTPDNEIDSFVK, KRYTPiso-DNEIDSFVK) were synthesized by N-(9-fluorenyl)methoxycarbonyl) biochemistry by Dr. Graham Bloomberg at the University of Bristol. Residue 1183 is highlighted in bold. Deamidation of TTCF—To permit spontaneous deamidation of TTCF, the protein was filter-sterilized and incubated in phosphate-buffered saline for 4-6 weeks at 37 °C (TTCF37). A control sample was incubated in parallel at 4 °C (TTCF4). Proteolytic Cleavage of TTCF by AEP—TTCF (0.5 mg/ml) was incubated at 37 °C with 10 mU/ml recombinant human AEP (prepared as described (17Li D.N. Matthews S.P. Antoniou A.N. Mazzeo D. Watts C. J. Biol. Chem. 2003; 278: 38980-38990Abstract Full Text Full Text PDF PubMed Scopus (138) Google Scholar)) in 50 mm acetate, pH 4.5, 5 mm dithiothreitol. At timed intervals, the reaction was stopped by the addition of 1 mm iodoacetamide. For pepsin digestions, TTCF (0.5 mg/ml) was incubated with 5 mU/ml pepsin (Sigma) in 50 mm sodium citrate, pH 4.0, 4 m urea. Proteolytic peptides were visualized on 12% Tris-Tricine SDS gels. Measurement of Iso-Aspartic Acid in TTCF—Iso-aspartyl residues were detected using the ISOQUANT™ protein deamidation detection kit (Promega Corp. Madison, WI) according to the manufacturer's instructions. Briefly, TTCF was incubated for 30 min with protein isoaspartyl methyl transferase and S-adenosyl-l-methionine. The formation of the methylation byproduct, S-adenosyl homocysteine, was detected by reversed phase HPLC. An S-adenosyl homocysteine standard curve was generated by calculating the area of the S-adenosyl homocysteine peak and used to estimate levels of iso-aspartic acid in unknown samples. Cell Lines and Media—T cell hybridomas specific for TTCF were generated as described (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar, 18West M.A. Wallin R.P.A. Matthews S.P. Svensson H.G. Zaru R. Cjunggren H-G. Prescott A.R. Watts C. Science. 2004; 305: 1153-1157Crossref PubMed Scopus (408) Google Scholar) and were maintained in RPMI supplemented with 10% heat-inactivated fetal calf serum, 2 mm glutamine, 100 μg/ml kanamycin, and 50 μm β-mercaptoethanol. The hybridoma specificities have been defined as follows: 1H3 recognizes amino acids 1145-1161, 1H3 and 4E4 recognize amino acids 950-966, and 5B12 recognizes amino acids 900-915 (18West M.A. Wallin R.P.A. Matthews S.P. Svensson H.G. Zaru R. Cjunggren H-G. Prescott A.R. Watts C. Science. 2004; 305: 1153-1157Crossref PubMed Scopus (408) Google Scholar). The murine B cell line LB27.4 was maintained in RPMI supplemented with 10% fetal calf serum, 2 mm glutamine, 100 μg/ml kanamycin, and 50 μm β-mercaptoethanol. T Cell Assays—In antigen titration assays, TTCF was added at the indicated concentrations to wells containing 1 × 105 antigen-presenting cells, together with 1 × 105 hybridomas. Assays were done in duplicate or triplicate in 96-well U-bottomed plates. After 24 h, the supernatants were removed, and the amount of IL-2 was determined by enzyme-linked immunosorbent assay using a mouse IL-2 OptEIA set (Pharmingen). In kinetic assays, antigen-presenting cells were incubated at 0.5-1 × 107/ml with 50 μg/ml TTCF. Cells were harvested at the indicated time points, fixed with 0.05% glutaraldehyde for 45 s, and quenched with 0.1 m glycine. Fixed cells (1 × 105/well) were added to an equivalent number of hybridomas, and the released IL-2 was measured after 24 h. Chromatography—Preparative and analytical chromatography was done on a SMART HPLC system (Amersham Biosciences). Cation exchange analysis of TTCF4 and TTCF37 was done using a Mini S 3.2/3 column (Amersham Biosciences) in 50 mm sodium acetate, pH 5.0, over a0-1 m NaCl gradient. Reversed phase chromatography was done on a C2/C18 SC 2.1/10 column (Amersham Biosciences) over a gradient ranging from 0.05% trifluoroacetic acid in water to 0.045% trifluoroacetic acid in 80% acetonitrile. Mass Spectrometry—TTCF was digested with sequencing grade trypsin (Promega) in 20 mm ammonium bicarbonate at an enzyme:protein ratio of 1:50 (w/w). Tryptic peptides were separated by reversed phase chromatography and concentrated in a vacuum centrifuge. HPLC fractions were analyzed individually on a Applied Biosystems Voyager-DE STR mass spectrometer. 1 μl of each crude peptide fraction was mixed with 1 μl of matrix (5 mg/ml α-cyano-4-hydroxycinnaminic acid in 50% acetonitrile, 48% water, 2% ammonium di-citrate) on a stainless steel MALDI plate and allowed to crystallize at room temperature. Fractions were analyzed individually on a Applied Biosystems Voyager-DE STR mass spectrometer. Positive ion MS spectra were acquired in reflectron mode. The extraction delay time was 180 ns, and the acceleration voltage set at 20 kV. Spectra were calibrated using an external standard. Whole tryptic TTCF digests derived from native and deamidated samples were analyzed by MALDI-TOF/TOF tandem MS analysis. The Applied Biosystems 4700 proteomics analyzer was used to determine the sites of deamidation. 1 μl from each digest was spotted onto a stainless steel MALDI target plate and allowed to dry. 1 μl of matrix was added to each digest sample and allowed to co-crystallize. Positive ion MS spectra were acquired in reflectron mode for each digest. Peptides 1214-1223 (DGNAFNNLDR) and 1179-1191 (YTPNNEIDSFVK) were sequenced by tandem MS analysis to determine the site of deamidation. “Aged” Tetanus Toxin C Fragment Resists AEP Digestion—We have shown previously that processing of TTCF is initiated by the asparagine-specific endopeptidase AEP and that glycosylation of target Asn residues or mutagenesis to Gln drastically inhibits AEP action (14Manoury B. Hewitt E.W. Morrice N. Dando P.M. Barrett A.J. Watts C. Nature. 1998; 396: 695-699Crossref PubMed Scopus (300) Google Scholar, 16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). Asparagine deamidation, which leads to the generation of aspartic or iso-aspartic acid (19Geiger T. Clarke S. J. Biol. Chem. 1987; 262: 785-794Abstract Full Text PDF PubMed Google Scholar), might also be expected to reduce the efficiency of AEP action. Using TTCF as a model antigen, we first tested whether spontaneous asparagine deamidation occurred in this protein and whether processing by AEP was affected. Aliquots of recombinant TTCF, dissolved in sterile phosphate-buffered saline, were stored either at 4 °C or at 37° for 4-6 weeks. No precipitation or autodigestion occurred, and the concentration of protein was the same at the end of the incubation period. The protein was then subjected to digestion with purified AEP, and the products were analyzed on 12% SDS gels. As shown previously (14Manoury B. Hewitt E.W. Morrice N. Dando P.M. Barrett A.J. Watts C. Nature. 1998; 396: 695-699Crossref PubMed Scopus (300) Google Scholar), a discrete set of digestion products is observed following cleavage at Asn residues 873, 1184, and 1219. Intact TTCF37 still persisted after 5 h of digestion, whereas TTCF4 was completely digested after 2-3 h of processing (Fig. 1A). At higher levels of AEP, additional Asn residues in TTCF are targeted. 2C. X. Moss, unpublished data. Peptides generated from cleavage by AEP at these minor sites were more prevalent in a digest of TTCF37, providing further evidence that aging TTCF perturbed the normal pattern of proteolytic degradation. Since asparagine deamidation leads to a net increase in negative charge and a gain of 1 mass unit, protein and peptide deamidation can be readily detected. Deamidation of Asn generates a mixture of Asp and iso-Asp, with l-iso-Asp comprising 60-80% (19Geiger T. Clarke S. J. Biol. Chem. 1987; 262: 785-794Abstract Full Text PDF PubMed Google Scholar). Thus, an additional diagnostic for deamidation is quantitation of iso-aspartic acid using the enzyme protein-l-iso-aspartate O-methyltransferase, which methylates the unusual α-carboxylic acid group on iso-aspartic acid. As shown in Fig. 1B, TTCF37 eluted from a cation exchange column before TTCF4, consistent with the former having gained net negative charge as a result of deamidation. In addition, direct analysis of iso-aspartic acid content showed that TTCF4 contained 1.08 mol of iso-Asp/mol of TTCF, whereas TTCF37 contained 3.56 mol/mol, a 3.3-fold increase. Thus, TTCF stored at 37 °C undergoes spontaneous deamidation and becomes more resistant to digestion by AEP. To address the possibility that other post-translational modifications were introduced into TTCF during the aging process, we examined the degradation of TTCF by other proteolytic or chemical agents. As pepsin prefers to cleave between pairs of hydrophobic residues, we predicted that deamidation of Asn would have no effect on substrate cleavage. As shown in Fig. 1C, pepsin degraded both TTCF37 and TTCF4. There was no significant difference in either the kinetics of degradation or in the pattern of fragments generated. In addition, both TTCF37 and TTCF4 were equally good substrates for CNBr digestion (data not shown), suggesting that methionine oxidation had not occurred to a significant extent. Taken together, these data indicate that the in vitro aging process did not grossly affect the susceptibility of TTCF to proteolytic or chemical processing. Asparagine Residues at and Adjacent to AEP Cleavage Sites Are Deamidated in TTCF37—To establish whether AEP processing sites had become deamidated in TTCF37, we subjected TTCF4 and TTCF37 samples to tryptic digestion and resolved the peptide products by reversed phase-HPLC (see “Experimental Procedures”). Individual fractions were analyzed by MALDI-TOF mass spectrometry. We identified two tryptic peptides with an isotopic distribution consistent with a proportion of the peptide having gained 1 mass unit. Interestingly, these were peptides containing AEP cleavage sites 1184 and 1219. As shown in Fig. 2A, the most abundant isotope for peptide 1214-1223 (DGNAFNNLDR) was the monoisotopic mass 1135.51 Da for TTCF4, but for TTCF37, the second isotopic mass of 1136.51 Da was the most abundant. Similarly, the isotopic distribution for peptide 1179-1191 (YTPPNNEIDSFVK) shifted upwards by one unit to 1427.68 Da. Although each peptide contains two adjacent Asn residues, AEP only cleaves at one site in each peptide (14Manoury B. Hewitt E.W. Morrice N. Dando P.M. Barrett A.J. Watts C. Nature. 1998; 396: 695-699Crossref PubMed Scopus (300) Google Scholar), illustrating that Asn sequence context plays an important, but as yet poorly understood, role in determining AEP target sites (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar, 20Dando P.M. Fortunato M. Smith L. Knight C.G. McKendrick J.E. Barrett A.J. Biochem. J. 1999; 339: 743-749Crossref PubMed Scopus (61) Google Scholar). To determine which Asn residue(s) had become deamidated, we sequenced each peptide using a MALDI-TOF/TOF tandem MS instrument. Inspection of the mass profile for each fragment ion generated from TTCF37 allowed us to identify the Asn residue that had become deamidated. As shown in Fig. 2B, the analysis for the 1214-1223 peptide demonstrated that residue 1219, which is the first of the paired Asn residues, had become converted to Asp/iso-Asp. When the analysis was performed for the 1179-1191 peptide, it was once again the first Asn residue of the pair (Asn-1183) that had become deamidated. No evidence was found for deamidation of Asn-1184, which is the AEP target in this region of TTCF (14Manoury B. Hewitt E.W. Morrice N. Dando P.M. Barrett A.J. Watts C. Nature. 1998; 396: 695-699Crossref PubMed Scopus (300) Google Scholar). Thus, we find evidence for deamidation in two regions of the TTCF molecule targeted by AEP. In one, the Asn cleaved by AEP is deamidated. In the other, an Asn residue immediately adjacent to an AEP cleavage site is similarly modified. Altered Presentation of Deamidated TTCF—Processing by AEP, particularly at Asn-1219, is required for optimal presentation of most T cell epitopes in TTCF (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). We therefore tested TTCF4 and TTCF37 in antigen presentation assays. For this, we used a panel of murine T cell hybridomas that recognize different epitopes in the TTCF antigen. We found no evidence for deamidation of Asn residues lying within these T cell epitopes; therefore, any effects are likely to be due to antigen uptake and/or processing rather than to the presentation of altered peptide ligands. We found that TTCF37 was much less efficient than TTCF4 in generating a T cell response in all hybridomas tested (Fig. 3), consistent with diminished processing of TTCF37. However, we were surprised by the magnitude of the inhibitory effect, which was greater than that obtained by mutagenesis of key AEP cleavage sites (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). This raised the possibility that deamidation and/or some other event occurring during aging was affecting not only processing of TTCF but some other parameter, for example, the efficiency of its uptake into antigen-presenting cells. TTCF37 Is Taken Up Less Efficiently by Antigen-presenting Cells—To investigate the possibility that TTCF37 was taken up less efficiently by antigen-presenting cells, we labeled TTCF and directly monitored the level of cell association. TTCF4 and TTCF37 were biotinylated, and the amount of biotin incorporated was shown to be equivalent in each case (Fig. 4A, lanes 1 and 2). When both forms of antigen were incubated with splenocytes (Fig. 4A), less Bi-TTCF37 was found associated with splenocytes at all time points when compared with Bi-TTCF4. This difference was evident even on cells incubated with Bi-TTCF4 or Bi-TTCF37 at 4 °C, indicating differential binding of the two TTCF forms to the cell surface. Although this differential association does not necessarily reflect the relative levels of TTCF4 and TTCF37 that are actually taken up and processed, it clearly indicates that diminished presentation of TTCF37 to T cells is likely to be due in part to weaker association with splenocytes when compared with TTCF4. Diminished AEP Processing Also Inhibits Presentation—We next asked whether the deficit in TTCF37 presentation was due to reduced processing by AEP in addition to diminished uptake. To address this, we needed to ensure that equal amounts of TTCF4 and TTC37 were taken up by cells, and we achieved this by using FcR-mediated uptake. Cells were provided with low concentrations of antigen, together with the TTCF-specific monoclonal antibodies 9B4 or 10G5. These antibodies bind equally well to both TTCF4 and TTCF37 as shown by enzyme-linked immunosorbent assay, and cell association of the two TTCF forms was now virtually equivalent (data not shown). As expected, inclusion of either antibody boosted presentation, indicating that the endocytic route was FcR-mediated (Fig. 4B). However, even under these conditions of comparable antigen association with cells, presentation of TTCF37 was markedly worse than TTCF4 (Fig. 4B). Thus, both reduced uptake and altered processing seem to contribute to the deficiency in presentation of peptides from TTCF37. Asp but Not Iso-Asp Is Tolerated Adjacent to the Asn-1184 AEP Cleavage Site—Although our earlier studies demonstrated that Asn-1219 was the most important AEP cleavage site for maximal presentation efficiency, mutagenesis of Asn-1184 also had a measurable deleterious effect on presentation to different T cell clones and hybridomas (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar) 2C. X. Moss, unpublished data.. We therefore asked whether deamidation of the adjacent residue 1183 might indirectly affect AEP processing at Asn-1184 and therefore contribute to the overall deficit in presentation of TTCF37. Mutation of Asn-1183 to Asp had little effect on in vitro digestion by AEP (Fig. 5A) nor on presentation of TTCF (Fig. 5B). However, natural Asn deamidation generates more iso-Asp relative to Asp. Because this induces a change in the conformation of the polypeptide chain, we reasoned that this might have a more profound effect on AEP cleavage at the adjacent (1184) Asn residue. To test this, we performed AEP digestions on synthetic peptides encompassing residues 1178-1191 of TTCF, which includes the 1184 cleavage site. We included Asn, Asp, or iso-Asp at position 1183. As shown in Fig. 5C, the time course of digestion of the Asn-1183 and Asp-1183 peptides was comparable, consistent with the modest effect when this mutation was expressed in TTCF protein. However, the presence of iso-Asp at 1183 markedly reduced the efficiency of digestion of the peptide. After 4 h of digestion, almost 60% of this peptide remained when compared with 10% of the wild type or 1183Asp peptides (Fig. 5B). Thus, it seems likely that at least three factors contribute to diminished presentation of TTCF37: reduced uptake, direct modification of the AEP cleavage site at Asn-1219, and indirect modification of the site at 1184 as a result of iso-Asp generation at 1183 (Fig. 6).Fig. 6TTCF structure and the location of deamidated AEP processing sites. The locations of AEP sites Asn-1184 and Asn-1219 are shown as ball-and-stick features on a ribbon model of TTCF. Deamidation occurs at Asn residues 1219 and 1183 (asterisked). Sequences surrounding the AEP cleavage sites and deamidated Asn residues are shown.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Here we demonstrate a distinct and novel effect of deamidation on T cell recognition of a protein antigen due, at least in part, to altered antigen processing. Our experiments were prompted by our recent studies on the asparagine-specific endopeptidase AEP (or legumain) found in human and murine APCs (21Watts C. Moss C.X. Mazzeo D. West M.A. Matthews S.P. Li D.N. Manoury B. Ann. N. Y. Acad. Sci. 2003; 987: 9-14Crossref PubMed Scopus (43) Google Scholar). Mammalian AEP or legumain is found in diverse cells and tissues including human and murine antigen-presenting cells (13Chen J.M. Dando P.M. Rawlings N.D. Brown M.A. Young N.E. Stevens R.A. Hewitt E. Watts C. Barrett A.J. J. Biol. Chem. 1997; 272: 8090-8098Abstract Full Text Full Text PDF PubMed Scopus (284) Google Scholar). It contributes to productive processing of antigens such as tetanus toxin and is one of the proteases that initiates removal of the invariant chain chaperone, which guides early class II major histocompatibility complex biosynthetic events (14Manoury B. Hewitt E.W. Morrice N. Dando P.M. Barrett A.J. Watts C. Nature. 1998; 396: 695-699Crossref PubMed Scopus (300) Google Scholar, 22Manoury B. Mazzeo D. Li D.N. Billson J. Loak K. Benaroch P. Watts C. Immunity. 2003; 18: 489-498Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar). We found evidence for deamidation of a key AEP processing site (Asn-1219) and evidence that a second site (Asn-1184) was indirectly affected by deamidation and β-isomerization of a neighboring Asn residue (Fig. 6). Deamidation altered the pattern of TTCF processing by AEP and suppressed presentation of different T cell epitopes in TTCF, consistent with our earlier studies on mutagenesis of key AEP processing sites (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). However, reduced uptake of TTCF37 also contributed to its poor presentation when compared with TTCF4. The reasons for this are not yet fully understood. The overall net increase in negative charge that accompanies conversion of Asn to Asp/iso-Asp (Fig. 1) may diminish binding given that the cell surface is also negatively charged. However, a mutant form of TTCF in which Asn-1183 and-1219 were changed to Asp was taken up equally well by cells (data not shown). However, it is also possible that deamidation of additional Asn residues in TTCF inhibits more specific interactions than TTCF makes with cells. For example, TTCF is known to bind gangliosides as well as other receptor structures on neuronal and possibly other cells (23Fotinou C. Emsley P. Black I. Ando H. Ishida H. Kiso M. Sinha K.A. Fairweather N.F. Isaacs N.W. J. Biol. Chem. 2001; 276: 32274-32281Abstract Full Text Full Text PDF PubMed Scopus (160) Google Scholar, 24Herreros J. Lalli G. Schiavo G. Biochem. J. 2000; 347: 199-204Crossref PubMed Scopus (90) Google Scholar). Although we were not able to identify modifications other than Asn deamidation, it remains a possibility that other modifications could have been introduced during in vitro aging and may contribute to the altered cell association of TTCF37. By complexing TTCF4 and TTCF37 with anti-TTCF antibodies that then drive uptake via Fc receptors, we could largely eliminate differential uptake of TTCF4 and TTCF37 (see also Ref. 16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). Even under these conditions, presentation of TTCF37 was significantly worse than TTCF4 due, we suggest, to deamidated AEP processing sites. In the case of the TTCF antigen, we did not observe instances of enhanced T cell epitope presentation as a result of Asn deamidation because of diminished uptake and presumably because AEP action on TTCF is required to initiate processing and is the first step for optimal presentation of most T cell epitopes (16Antoniou A.N. Blackwood S.L. Mazzeo D. Watts C. Immunity. 2000; 12: 391-398Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). However, it is possible that loss of processing sites (for AEP or other enzymes) as a result of post-translational protein modifications might enhance the presentation of T cell epitopes in other antigens/autoantigens. This idea is supported by recent evidence that proteolytic processing reactions, for both class I and class II major histocompatibility complex epitopes, can be destructive as well as productive (25Beck H. Schwarz G. Schroter C.J. Deeg M. Baier D. Stevanovic S. Weber E. Driessen C. Kalbacher H. Eur. J. Immunol. 2001; 31: 3726-3736Crossref PubMed Scopus (89) Google Scholar, 26Manoury B. Mazzeo D. Fugger L. Viner N. Ponsford M. Streeter H. Mazza G. Wraith D.C. Watts C. Nat. Immunol. 2002; 3: 169-174Crossref PubMed Scopus (174) Google Scholar, 27Saric T. Beninga J. Graef C.I. Akopian T.N. Rock K.L. Goldberg A.L. J. Biol. Chem. 2001; 276: 36474-36481Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar). An example of this, which also illustrates how direct and indirect effects of Asn deamidation on immune recognition can be linked, is seen in the case of another AEP substrate, myelin basic protein (MBP). A T cell epitope lying between residues 85-99 in MBP is destroyed by AEP cleavage at Asn-94 (25Beck H. Schwarz G. Schroter C.J. Deeg M. Baier D. Stevanovic S. Weber E. Driessen C. Kalbacher H. Eur. J. Immunol. 2001; 31: 3726-3736Crossref PubMed Scopus (89) Google Scholar, 26Manoury B. Mazzeo D. Fugger L. Viner N. Ponsford M. Streeter H. Mazza G. Wraith D.C. Watts C. Nat. Immunol. 2002; 3: 169-174Crossref PubMed Scopus (174) Google Scholar). We have shown that presentation of this peptide to MBP-specific T cells is inversely proportional to AEP activity and have suggested that T cells specific for this region of MBP escape tolerization in the thymus because of this destructive processing reaction (26Manoury B. Mazzeo D. Fugger L. Viner N. Ponsford M. Streeter H. Mazza G. Wraith D.C. Watts C. Nat. Immunol. 2002; 3: 169-174Crossref PubMed Scopus (174) Google Scholar). Deamidation of Asn-94 would eliminate a dominant AEP processing site in MBP, allowing survival of the 85-99 peptide with a change to Asp or iso-Asp in position 94, which might appear foreign to the immune system. T cell reactivity to MBP85-99 is thought to be important in the inflammatory reactions that occur in multiple sclerosis, and some (although not all) T cells isolated from multiple sclerosis patients that are specific for MBP 85-99 are able to recognize Asp in position 94 (28Wucherpfennig K.W. Strominger J.L. Cell. 1995; 80: 695-705Abstract Full Text PDF PubMed Scopus (1266) Google Scholar). However, at this point, this scenario is speculative, and our initial attempts to demonstrate deamidation of Asn-94 in the MBP 85-99 peptide over the short time scales used in our TTCF studies have not been successful. Rates of deamidation of asparagine residues are dependent on a number of variables, among them the amino acid residue C-terminal to the Asn and the conformational flexibility of the polypeptide chain in that region. Although the slow turnover of MBP would in principle allow deamidated Asn residues to accumulate over time, the residue that follows Asn-94 in MBP, Ile-95, is not optimal for deamidation of Asn-94 (29Robinson N.E. Robinson A.B. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 4367-4372Crossref PubMed Scopus (172) Google Scholar, 30Robinson N.E. Robinson Z.W. Robinson B.R. Robinson A.L. Robinson J.A. Robinson M.L. Robinson A.B. J. Pept. Res. 2004; 63: 426-436Crossref PubMed Scopus (160) Google Scholar). Nonetheless, it remains an intriguing possibility that deamidation of Asn-94 occurs in MBP over longer time scales and that this contributes to the autoreactivity to this protein seen in multiple sclerosis. In TTCF, we found that two different surface loops, each containing a pair of Asn residues, were deamidated on the first Asn of the pair (Fig. 6). The most comprehensive studies on rates of Asn deamidation did not include a second Asn as the C-terminal residue (presumably because of its own potential instability), but Asp, although not optimal, was permissible (29Robinson N.E. Robinson A.B. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 4367-4372Crossref PubMed Scopus (172) Google Scholar, 30Robinson N.E. Robinson Z.W. Robinson B.R. Robinson A.L. Robinson J.A. Robinson M.L. Robinson A.B. J. Pept. Res. 2004; 63: 426-436Crossref PubMed Scopus (160) Google Scholar). The structure of the TTCF antigen shows that the loop containing Asn-1183/-1844 is exceptionally exposed and might be expected to be flexible in solution (31Umland T.C. Wingert L.M. Swaminathan S. Furey W.F. Schmidt J.J. Sax M. Nat. Struct. Biol. 1997; 4: 788-792Crossref PubMed Scopus (137) Google Scholar, 32Emsley P. Fotinou C. Black I. Fairweather N.F. Charles I.G. Watts C. Hewitt E. Isaacs N.W. J. Biol. Chem. 2000; 275: 8889-8894Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar) (Fig. 6). It is interesting to speculate that loss of AEP sites as a result of deamidation might concomitantly generate new sites for proteases specific for Asp in the P1 position. The caspases are Asp-specific proteases, although the distinct compartmental localizations of AEP (endosomes/lysosomes) and caspases (cytosol) might rule out their involvement. Another Asp-specific protease is granzyme B found in the cytolytic granules of T and NK cells. Interestingly, Casciola-Rosen et al. (33Casciola-Rosen L. Andrade F. Ulanet D. Wong W.B. Rosen A. J. Exp. Med. 1999; 190: 815-826Crossref PubMed Scopus (425) Google Scholar) have demonstrated that granzyme B generates unique fragments from many known and putative human autoantigens. They propose that by so doing granzyme B action, for example, on apoptotic cell debris, might trigger an autoreactive response. They propose that sensitivity to granzyme B (but not to caspase 8, which has similar specificity) is a hallmark of candidate autoantigens. If this hypothesis is correct, it is interesting to speculate that Asn deamidation might produce new granzyme B substrates and that this might be a further connection between Asn deamidation and autoreactivity. In summary, extrapolating from the example of tetanus toxin, we speculate that long-lived self-proteins, the Asn residues of which become spontaneously deamidated, may be differently processed by AEP when compared with their younger, and in particular their thymically expressed, counterparts. Post-translational modifications to proteins constitute a potential hazard to immune tolerance because there is no certainty that a particular modification will be represented in the protein substrate “mix” available for thymic antigen presentation. Differential processing of self-proteins, between the thymus, where central tolerance is established, and peripheral tissues, is thought to be one of the factors that create permissive conditions for induction and/or maintenance of autoimmune disease (8Doyle H.A. Mamula M.J. Trends Immunol. 2001; 22: 443-449Abstract Full Text Full Text PDF PubMed Scopus (235) Google Scholar, 34Sercarz E.E. Lehmann P.V. Ametani A. Benichou G. Miller A. Moudgil K. Annu. Rev. Immunol. 1993; 11: 729-766Crossref PubMed Scopus (797) Google Scholar). Finally, our results, and earlier results reporting that storage of peptides led to distinct immune recognition patterns as a result of deamidation (5Chen W. Ede N.J. Jackson D.C. McCluskey J. Purcell A.W. J. Immunol. 1996; 157: 1000-1005PubMed Google Scholar, 6Cirrito T.P. Pu Z. Deck M.B. Unanue E.R. J. Exp. Med. 2001; 194: 1165-1169Crossref PubMed Scopus (22) Google Scholar, 7McAdam S.N. Fleckenstein B. Rasmussen I.B. Schmid D.G. Sandlie I. Bogen B. Viner N.J. Sollid L.M. J. Exp. Med. 2001; 193: 1239-1246Crossref PubMed Scopus (33) Google Scholar), raise the possibility that long term storage of vaccines in solution might lead to deamidation of Asn residues that are either important for T cell recognition or key AEP target residues and consequently influence processing, and thus indirectly, the display of important T cell epitopes. We thank Doreen Keane for technical assistance and Henrik Svensson and Robert Wallin for helpful comments on the manuscript." @default.
• W2169353837 created "2016-06-24" @default.
• W2169353837 creator A5001667624 @default.
• W2169353837 creator A5063492360 @default.
• W2169353837 creator A5076915144 @default.
• W2169353837 creator A5088125040 @default.
• W2169353837 date "2005-05-01" @default.
• W2169353837 modified "2023-10-05" @default.
• W2169353837 title "Asparagine Deamidation Perturbs Antigen Presentation on Class II Major Histocompatibility Complex Molecules" @default.
• W2169353837 cites W1572039642 @default.
• W2169353837 cites W1591227306 @default.
• W2169353837 cites W1680217275 @default.
• W2169353837 cites W1944789189 @default.
• W2169353837 cites W1965392890 @default.
• W2169353837 cites W1976342692 @default.
• W2169353837 cites W1976844387 @default.
• W2169353837 cites W1977235209 @default.
• W2169353837 cites W1979680810 @default.
• W2169353837 cites W1980694300 @default.
• W2169353837 cites W1994209619 @default.
• W2169353837 cites W1997852469 @default.
• W2169353837 cites W2004709114 @default.
• W2169353837 cites W2006493141 @default.
• W2169353837 cites W2010730959 @default.
• W2169353837 cites W2012178046 @default.
• W2169353837 cites W2013909260 @default.
• W2169353837 cites W2018027744 @default.
• W2169353837 cites W2021828942 @default.
• W2169353837 cites W2061016075 @default.
• W2169353837 cites W2063366729 @default.
• W2169353837 cites W2074371882 @default.
• W2169353837 cites W2075724968 @default.
• W2169353837 cites W2080602313 @default.
• W2169353837 cites W2080891856 @default.
• W2169353837 cites W2081643248 @default.
• W2169353837 cites W2085382985 @default.
• W2169353837 cites W2101577079 @default.
• W2169353837 cites W2113819336 @default.
• W2169353837 cites W2133301540 @default.
• W2169353837 cites W2135926596 @default.
• W2169353837 cites W2160823674 @default.
• W2169353837 cites W2163357710 @default.
• W2169353837 cites W4239560737 @default.
• W2169353837 doi "https://doi.org/10.1074/jbc.m501241200" @default.
• W2169353837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15749706" @default.
• W2169353837 hasPublicationYear "2005" @default.
• W2169353837 type Work @default.
• W2169353837 sameAs 2169353837 @default.
• W2169353837 citedByCount "66" @default.
• W2169353837 countsByYear W21693538372012 @default.
• W2169353837 countsByYear W21693538372013 @default.
• W2169353837 countsByYear W21693538372014 @default.
• W2169353837 countsByYear W21693538372015 @default.
• W2169353837 countsByYear W21693538372016 @default.
• W2169353837 countsByYear W21693538372017 @default.
• W2169353837 countsByYear W21693538372018 @default.
• W2169353837 countsByYear W21693538372019 @default.
• W2169353837 countsByYear W21693538372020 @default.
• W2169353837 countsByYear W21693538372021 @default.
• W2169353837 countsByYear W21693538372022 @default.
• W2169353837 countsByYear W21693538372023 @default.
• W2169353837 crossrefType "journal-article" @default.
• W2169353837 hasAuthorship W2169353837A5001667624 @default.
• W2169353837 hasAuthorship W2169353837A5063492360 @default.
• W2169353837 hasAuthorship W2169353837A5076915144 @default.
• W2169353837 hasAuthorship W2169353837A5088125040 @default.
• W2169353837 hasBestOaLocation W21693538371 @default.
• W2169353837 hasConcept C104317684 @default.
• W2169353837 hasConcept C147483822 @default.
• W2169353837 hasConcept C154317977 @default.
• W2169353837 hasConcept C181199279 @default.
• W2169353837 hasConcept C185592680 @default.
• W2169353837 hasConcept C202751555 @default.
• W2169353837 hasConcept C207936829 @default.
• W2169353837 hasConcept C2775895851 @default.
• W2169353837 hasConcept C2780784506 @default.
• W2169353837 hasConcept C515207424 @default.
• W2169353837 hasConcept C54355233 @default.
• W2169353837 hasConcept C55493867 @default.
• W2169353837 hasConcept C70721500 @default.
• W2169353837 hasConcept C83464605 @default.
• W2169353837 hasConcept C86803240 @default.
• W2169353837 hasConceptScore W2169353837C104317684 @default.
• W2169353837 hasConceptScore W2169353837C147483822 @default.
• W2169353837 hasConceptScore W2169353837C154317977 @default.
• W2169353837 hasConceptScore W2169353837C181199279 @default.
• W2169353837 hasConceptScore W2169353837C185592680 @default.
• W2169353837 hasConceptScore W2169353837C202751555 @default.
• W2169353837 hasConceptScore W2169353837C207936829 @default.
• W2169353837 hasConceptScore W2169353837C2775895851 @default.
• W2169353837 hasConceptScore W2169353837C2780784506 @default.
• W2169353837 hasConceptScore W2169353837C515207424 @default.
• W2169353837 hasConceptScore W2169353837C54355233 @default.
• W2169353837 hasConceptScore W2169353837C55493867 @default.
• W2169353837 hasConceptScore W2169353837C70721500 @default.
• W2169353837 hasConceptScore W2169353837C83464605 @default.
• W2169353837 hasConceptScore W2169353837C86803240 @default.
• W2169353837 hasIssue "18" @default.

• next